Certified by Founder Lodge
Adjuvant Capital
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $53,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Adjuvant Capital is a life sciences investment firm focused on global health. We make $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected d
| Company | Date | Round | Raised |
|---|---|---|---|
 Antiva Biosciences, Inc. |
April, 27 ,2023 | Series E | $53,000,000 |
 Curevo Vaccine |
March, 19 ,2025 | Series B | $110,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
